Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Clinical Trials for Eczema (Atopic Dermatitis)

PEER Services

Clinical Trials Logo

The icon above indicates a trial that has been approved for premier listing status.

If you are a clinic or a researcher who would like to apply for premier listing status, or learn more about NEA’s People Engaged in Eczema Research (PEER) services, please click here.

A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in five phases. Participants can help themselves and others by contributing to medical research.

 

The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. Please click on the title of the research study for more information. Please feel free to contact the NEA office for more information.

Search & Filters

By Location
By Status
By Phase
By Condition
By Intervention

Trial Postings

Showing results

Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

    Condition:
  • Moderate-to-Severe Atopic Dermatitis

Recruiting

  • Little Rock, Arkansas
  • Beverly Hills, California
  • Fountain Valley, California
  • Lomita, California
  • Los Angeles, California
  • San Diego, California
  • San Francisco, California
  • Santa Monica, California
  • Walnut Creek, California
  • Bridgeport, Connecticut
  • Washington, District of Columbia
  • Washington, District of Columbia
  • Boynton Beach, Florida
  • Cape Coral, Florida
  • Hialeah, Florida
  • Hialeah, Florida
  • Jacksonville, Florida
  • Miami Lakes, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Pembroke Pines, Florida
  • Albany, Georgia
  • Macon, Georgia
  • Newnan, Georgia
  • Boise, Idaho
  • Nampa, Idaho
  • Skokie, Illinois
  • Skokie, Illinois
  • Indianapolis, Indiana
  • Louisville, Kentucky
  • Ann Arbor, Michigan
  • Bay City, Michigan
  • Troy, Michigan
  • Ypsilanti, Michigan
  • Saint Joseph, Missouri
  • Missoula, Montana
  • Omaha, Nebraska
  • Henderson, Nevada
  • Lebanon, New Hampshire
  • Albuquerque, New Mexico
  • Brooklyn, New York
  • New York, New York
  • New York, New York
  • Durham, North Carolina
  • Wilmington, North Carolina
  • Wilmington, North Carolina
  • Bexley, Ohio
  • Dublin, Ohio
  • Norman, Oklahoma
  • Philadelphia, Pennsylvania
  • Plymouth Meeting, Pennsylvania
  • Charleston, South Carolina
  • Rapid City, South Dakota
  • Chattanooga, Tennessee
  • Arlington, Texas
  • Austin, Texas
  • Cypress, Texas
  • Dallas, Texas
  • Dripping Springs, Texas
  • Frisco, Texas
  • Houston, Texas
  • Houston, Texas
  • Burke, Virginia
  • Darlinghurst, New South Wales
  • Kogarah, New South Wales
  • Benowa, Queensland
  • Woolloongabba, Queensland
  • Woodville, South Australian
  • Carlton, Victoria
  • East Melbourne, Victoria
  • Parkville, Victoria
  • Parkville, Victoria
  • Fremantle, Western Australia
  • Victoria Park, Western Australia
  • Graz, Styria
  • Linz
  • Vienna
  • Wien
  • Calgary
  • Calgary
  • Edmonton
  • Edmonton
  • Edmonton
  • Hamilton
  • Niagara Falls
  • Ottawa
  • Saint John
  • Saint John
  • Sudbury
  • Toronto
  • Toronto
  • Waterloo
  • Brno
  • Náchod
  • Olomouc
  • Pardubice
  • Prague
  • Praha
  • Praha
  • Praha
  • Langenau, Hesse
  • Witten, Hesse
  • Tuebingen, Niedersachesen
  • Berlin, NRW
  • Kiel, Schleswig-Holst
  • Bad Bentheim
  • Berlin
  • Berlin
  • Berlin
  • Bielefeld
  • Buxtehude
  • Darmstadt
  • Dülmen
  • Friedrichshafen
  • Hamburg
  • Hannover
  • Leipzig
  • Lubeck
  • Münster
  • Osnabrück
  • Stuttgart
  • Bucheon
  • Busan
  • Gyeonggi-do
  • Gyeonggi-do
  • Incheon
  • Incheon
  • Incheon
  • Seoul
  • Seoul
  • Seoul
  • Seoul
  • Seoul
  • Seoul
  • Seoul
  • Seoul
  • Liepāja
  • Riga
  • Riga
  • Talsi
  • Ventspils
  • Kaunas
  • Klaipėda
  • Vilnius
  • Vilnius
  • Vilnius
  • Bergen Op Zoom
  • Groningen
  • Rotterdam
  • Utrecht
  • Christchurch
  • Hamilton
  • Wellington
  • Alicante
  • Barcelona
  • Barcelona
  • Barcelona
  • Barcelona
  • Las Palmas De Gran Canaria
  • Madrid
  • Madrid
  • Madrid
  • Madrid
  • Majadahonda
  • Málaga
  • Pamplona
  • Valencia
  • Zaragoza
  • Barnsley
  • Blackpool
  • Cannock
  • Dudley
  • Lanark
  • Liverpool
  • London
  • London
  • Manchester
  • Newcastle
  • Poole
  • Redhill
  • Stockton-on-Tees

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

    Condition:
  • Moderate-to-Severe Atopic Dermatitis

Recruiting

  • Birmingham, Alabama
  • Scottsdale, Arizona
  • Encinitas, California
  • Fremont, California
  • Los Angeles, California
  • Ontario, California
  • Pasadena, California
  • San Diego, California
  • San Diego, California
  • Santa Ana, California
  • Hialeah, Florida
  • Largo, Florida
  • Miami, Florida
  • Miami, Florida
  • Miami, Florida
  • Oakland Park, Florida
  • Tampa, Florida
  • West Palm Beach, Florida
  • Columbus, Georgia
  • Stockbridge, Georgia
  • Rolling Meadows, Illinois
  • New Albany, Indiana
  • Farmington Hills, Michigan
  • Warren, Michigan
  • Omaha, Nebraska
  • Omaha, Nebraska
  • Las Vegas, Nevada
  • Buffalo, New York
  • Cortland, New York
  • New York, New York
  • Raleigh, North Carolina
  • Cincinnati, Ohio
  • Norman, Oklahoma
  • Portland, Oregon
  • Pittsburgh, Pennsylvania
  • Plymouth Meeting, Pennsylvania
  • Sugarloaf, Pennsylvania
  • North Charleston, South Carolina
  • Chattanooga, Tennessee
  • Houston, Texas
  • Houston, Texas
  • Waco, Texas
  • Webster, Texas
  • Salt Lake City, Utah
  • Brussel
  • Edegem
  • Gent
  • Leuven
  • Liège
  • Pleven
  • Plovdiv
  • Sofia
  • Sofia
  • Sofia
  • Sofia
  • Sofia
  • Sofia
  • Sofia
  • Sofia
  • Stara Zagora
  • Tallinn
  • Tallin
  • Tartu
  • Brest
  • Lille
  • Martigues
  • Nantes
  • Paris
  • Paris
  • Pierre-Bénite
  • Toulouse
  • Valence
  • Aachen
  • Augsburg
  • Augsburg
  • Bonn
  • Dresden
  • Duesseldorf
  • Frankfurt am main
  • Gera
  • Goettigen
  • Halle
  • Hamburg
  • Hamburg
  • Hamburg
  • Heidelberg
  • Kiel
  • Mainz
  • Munich
  • München
  • Budapest
  • Budapest
  • Debrecen
  • Szeged
  • Szekszárd
  • Veszprém
  • Ancona
  • Bologna
  • Catania
  • Chieti
  • Florence
  • Genova
  • L'Aquila
  • Messina
  • Milan
  • Modena
  • Naples
  • Parma
  • Pavia
  • Perugia
  • Pisa
  • Roma
  • Roma
  • Rome
  • Rozzano
  • Torino
  • Vicenza
  • Seoul
  • Białystok
  • Chorzów
  • Cracovia
  • Gdansk
  • Gdańsk
  • Katowice
  • Katowice
  • Katowice
  • Kraków
  • Lublin
  • Lublin
  • Nowa Sól
  • Olsztyn
  • Poznań
  • Poznań
  • Rzeszów
  • Szczecin
  • Tarnów
  • Warsaw
  • Warsaw
  • Warszawa
  • Warszawa
  • Warszawa
  • Wrocław
  • Wrocław
  • Wrocław
  • Wrocław
  • Łódź
  • Cluj-Napoca
  • Iaşi
  • Sibiu
  • Singapore
  • Singapore
  • Singapore
  • Singapore

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

    Condition:
  • Cutaneous T-cell Lymphoma
  • Sezary Syndrome
  • Mycosis Fungoides
  • Eczema
  • Atopic Dermatitis

Recruiting

  • Pittsburgh, Pennsylvania

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

    Condition:
  • Atopic Dermatitis

Recruiting

  • Philadelphia, Pennsylvania

Studies of Skin Microbes in Healthy People and in People With Skin Conditions

    Condition:
  • Atopic Dermatitis
  • Eczema
  • Ichthyosis Vulgaris

Recruiting

  • Bethesda, Maryland

Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways

    Condition:
  • PLAID
  • Atopic Dermatitis
  • CARD11
  • CARD14
  • Hereditary Alpha Trytasemia

Recruiting

  • Bethesda, Maryland

Systemic Therapies for Pediatric Atopic Dermatitis

    Condition:
  • Dermatitis, Atopic

Recruiting

  • San Diego, California
  • San Francisco, California
  • Chicago, Illinois

Effects of Treatments on Atopic Dermatitis

    Condition:
  • Eczema
  • Dermatitis
  • Skin Diseases, Genetic
  • Dermatitis, Atopic
  • Skin Diseases

Recruiting

  • Bethesda, Maryland

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

    Condition:
  • Atopic Dermatitis
  • Eczema

Recruiting

  • Chicago, Illinois
  • Chicago, Illinois
  • Northbrook, Illinois
  • New York, New York

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

    Condition:
  • All Diagnosed Health Conditions
  • ADD/ADHD
  • Alopecia Areata
  • Ankylosing Spondylitis
  • Asthma
  • Atopic Dermatitis Eczema
  • Beta Thalassemia
  • Bipolar Disorder
  • Breast Cancer
  • Celiac Disease
  • Cervical Cancer
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Chronic Kidney Diseases
  • Chronic Obstructive Pulmonary Disease
  • Colon Cancer
  • Colorectal Cancer
  • Crohn's Disease
  • Cystic Fibrosis
  • Depression
  • Diabetes Mellitus
  • Duchenne Muscular Dystrophy
  • Endometriosis
  • Epilepsy
  • Facioscapulohumeral Muscular Dystrophy
  • G6PD Deficiency
  • General Anxiety Disorder
  • Hepatitis B
  • Hereditary Hemorrhagic Telangiectasia
  • HIV/AIDS
  • Human Papilloma Virus
  • Huntington's Disease
  • Idiopathic Thrombocytopenic Purpura
  • Insomnia
  • Kidney Cancer
  • Leukemia
  • Lung Cancer
  • Lupus Nephritis
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myositis
  • Myotonic Dystrophy
  • Ovarian Cancer
  • Pancreatic Cancer
  • Parkinson's Disease
  • Polycystic Kidney Diseases
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Rosacea
  • Scleroderma
  • Sickle Cell Anemia
  • Sickle Cell Trait
  • Sjogren's Syndrome
  • Skin Cancer
  • Spinal Muscular Atrophy
  • Systemic Lupus Erythematosus
  • Thrombotic Thrombocytopenic Purpura
  • Trisomy 21
  • Ulcerative Colitis

Recruiting

  • Los Angeles, California

Can Vitamin D Supplementation in Infants Prevent Food Allergy in the First Year of Life? The VITALITY Trial

    Condition:
  • Food Allergy

Recruiting

  • Melbourne, Victoria

Treatment of Chronic Itch in Atopic Dermatitis (Eczema)

    Condition:
  • Cutaneous Nerves CNS Itch

Recruiting

  • Minneapolis, Minnesota

Inflammatory Cells From Various Pathologies

    Condition:
  • Atopic Dermatitis
  • Acne Rosacea
  • Acne Vulgaris

Recruiting

  • Montreal, Quebec

PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo

    Condition:
  • Atopic Dermatitis

Recruiting

  • Angers
  • Bordeaux
  • Brest
  • Bron
  • Chambray Les Tours
  • La Roche sur Yon
  • Le Mans
  • Lille
  • Nantes
  • Paris
  • Perigueux
  • Quimper
  • Rennes
  • Saint Brieuc
  • Valence
  • Valenciennes

A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months

    Condition:
  • Dermatitis, Atopic

Recruiting

  • Bordeaux
  • Brest
  • Lille
  • Lyon
  • Marseille
  • Montpellier
  • Nancy
  • Nantes
  • Nice
  • Rennes
  • Toulouse

National Eczema Association Clinical Research Trials Policy

The National Eczema Association (NEA) is committed to improving patients’ quality of life through research, education, and support. NEA does not provide medical advice to patients but provides information to help them better understand their health, diagnosed conditions and the current range of approaches related to eczema treatment, prevention and supportive care. NEA urges patients to consult with a qualified physician for diagnosis and treatment.

As part of the fulfillment of its mission, NEA provides information to its constituents regarding clinical research trial availability and participation. NEA does not recruit patients for clinical trials and NEA does not conduct clinical trials. Below is a notice for a research study that we thought might be of interest to you. NEA is providing this information as a service. NEA does not endorse the study, which is being conducted at locations and under protocols that are not monitored or reviewed by NEA. Accordingly, NEA cannot be held responsible for anything that may occur in connection with the study. NEA may be reimbursed by the sponsor of the study for costs incurred in connection with notifying NEA constituents of the availability of the study. Should you have any questions regarding the study, please contact the study sponsor.

NEA respects your privacy and does not release your private information to any outside individuals, companies or organizations. Please see complete NEA Clinical Trials Policy here.

About Our Database Sources

ClinicalTrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world.